A recent study published in the journal Nature Microbiology showed that exoglycosidases from Akkermansia muciniphila, a gut symbiont, can target (extended) blood group antigens to produce ...

Veterinary hematology and transfusion medicine represent a dynamic and critical field that underpins the diagnosis and treatment of a wide range of clinical conditions in animal health. Extensive ...

“The Transfusion Medicine Service in the Department of Pathology performs therapeutic apheresis on patients who have an illness associated with an abnormal cellular or plasma-based blood component,” ...

FDA-approved MTS™ DAT Card and advanced ORTHO VISION™ Platform highlight the company's continued leadership in transfusion medicine SAN DIEGO, Oct. 16, 2025 /PRNewswire/ -- QuidelOrtho Corporation ...

A new study led by investigators from Mass General Brigham and Yale School of Public Health reveals that red blood cell exchange transfusion (ET) may provide critical benefits for patients ...

Patricia Ford, MD, a leader in bloodless medicine and transfusion-free oncology, discusses her career and how she became the ...

RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...

Dr. Metcalf is Section Chief of Transfusion Medicine, Associate Professor of Pathology, and Inpatient Chief Value Officer for the Department of Pathology at the University of Utah Health and ARUP ...

Criteria for superior efficacy not met in trial involving air ambulances ...

Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter GVS S.p.A. has strengthened its ...

QuidelOrtho (NASDAQ:QDEL) is considering the sale of its transfusion medicine business, which may be valued at $1.5 billion to $2 billion. QuidelOrtho rose 1.6% in after hours trading. The diagnostics ...